| Literature DB >> 33496721 |
Gelu Simu1, Radu Rosu2, Gabriel Cismaru1, Mihai Puiu1, Gabriel Gusetu1, Ioan Minciuna1, Sabina Istratoaie3, Raluca Tomoaia1, Dumitru Zdrenghea1, Dana Pop1.
Abstract
Cardiac electronic implantable devices (CIEDs) have the ability to monitor, store and interpret complex arrhythmias, which has generated a new arrhythmic entity: atrial high-rate episodes (AHRE). AHRE are atrial tachyarrhythmias, detected only by CIEDs. They are widely considered a precursor to atrial fibrillation (AF) but can also be represented by other kinds of supraventricular arrhythmias such as atrial flutter or atrial tachycardia. CIED-detected AHRE are associated with an increased risk of stroke, but the risk is significantly lower than the stroke risk of clinical AF. Moreover, there seems to be no temporal correlation between AHRE and thromboembolic events. Because of the current gaps in evidence, the appropriate management of this arrythmia can be challenging. In this review we take into account the epidemiology behind AHRE, predictive factors, clinical impact and management of this arrhythmia.Entities:
Keywords: anticoagulant agents; atrial fibrillation; atrial high‐rate episodes ; pacemaker; stroke
Mesh:
Substances:
Year: 2021 PMID: 33496721 PMCID: PMC9219569 DOI: 10.5830/CVJA-2020-052
Source DB: PubMed Journal: Cardiovasc J Afr ISSN: 1015-9657 Impact factor: 0.802